港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

諾誠健華

成交量：- -

成交額：- -

市值：- -

市盈率：- -

高：- -

開：- -

低：- -

收：- -

資料載入中...

總覽公司新聞公告

諾誠健華在第62屆美國血液學協會（ASH）上公佈奧布替尼最新臨牀數據

昌發展投資企業諾誠健華、數坤科技、吉因加取得重大進展

諾誠健華董事長兼CEO崔霽松博士獲評2020“年度傑出CEO”

百濟神州、和黃醫藥、亞盛醫藥、諾誠健華等創新產品即將亮相

药明康德官微

諾誠健華-B盤中異動大幅上漲5.11%

自选股智能写手

諾誠健華童少靖：中國創新藥以高質量和高性價比吸引發達國家市場、並受發展中國家市場青睞是必然趨勢

金融界网站

諾誠健華“泛癌種”新藥啓動臨牀試驗

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/90009/news?page=4"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"90009","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"90009\",,,,,undefined,":{"symbol":"90009","market":"HK","secType":"STK","nameCN":"諾誠健華","latestPrice":0,"timestamp":0,"preClose":0,"halted":9,"volume":0,"delay":0,"floatShares":25034000,"shares":225290000,"eps":0,"marketStatus":"交易中","change":0,"latestTime":"06-06 14:46:42","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1749197400000},"marketStatusCode":2,"adr":0,"listingDate":1584892800000,"exchange":"SEHK","adjPreClose":0,"openAndCloseTimeList":[[1749173400000,1749182400000],[1749186000000,1749196800000]],"volumeRatio":0,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688428","market":"SH","secType":"STK","nameCN":"諾誠健華","latestPrice":24.4,"timestamp":1749192401000,"preClose":23.98,"halted":0,"volume":4642600,"delay":0,"premium":"-100.00"}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"90009\",,,,,undefined,":{"symbol":"90009","floatShares":25034000,"roa":"--","roe":"--","lyrEps":0,"shares":225290000,"dividePrice":0,"high":0,"amplitude":0,"preClose":0,"low":0,"week52Low":0,"pbRate":"--","week52High":0,"institutionHeld":0,"latestPrice":0,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"90009\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2089488094","title":"諾誠健華在第62屆美國血液學協會（ASH）上公佈奧布替尼最新臨牀數據","url":"https://stock-news.laohu8.com/highlight/detail?id=2089488094","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2089488094?lang=zh_tw&edition=fundamental","pubTime":"2020-12-07 12:18","pubTimestamp":1607314680,"startTime":"0","endTime":"0","summary":"诺诚健华在第62届美国血液学协会上公布奥布替尼最新临床数据 来源：美通社北京2020年12月7日 /美通社/ -- 生物医药高科技公司诺诚健华今天在第62届美国血液学协会年会上公布了布鲁顿酪氨酸激酶抑制剂奥布替尼最新临床数据。目前，奥布替尼正在中国及美国进行多中心、多适应症的临床试验，研究其作为单药及联合用药的疗效和安全性，临床结果显示了良好的安全性和有效性。现有多个新药产品处于临床及临床前研发阶段。","market":"sh","thumbnail":"https://static.tigerbbs.com/480431b5715196c0e96044cc36788e36","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/480431b5715196c0e96044cc36788e36"],"rights":{"source":"sina_symbol","url":"http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2020-12-07/doc-iiznezxs5622548.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.extra-info, .source{#sourceStyle#;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2020-12-07/doc-iiznezxs5622548.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_symbol","symbols":["09969","90009"],"gpt_icon":0},{"id":"2084470643","title":"昌發展投資企業諾誠健華、數坤科技、吉因加取得重大進展","url":"https://stock-news.laohu8.com/highlight/detail?id=2084470643","media":"网络","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2084470643?lang=zh_tw&edition=fundamental","pubTime":"2020-11-19 10:44","pubTimestamp":1605753840,"startTime":"0","endTime":"0","summary":"近日，昌发展投资企业在多个方面取得重大突破。昌发展与合作基金联合投资企业诺诚健华今年3月于港交所成功上市，成为2020年第一家在港交所成功上市的生物医药公司。据悉，数坤科技为昌发展间接投资企业，昌发展合作子基金远毅资本和华盖资本参与其融资。","market":"hk","thumbnail":"https://static.tigerbbs.com/769dc8865e0dc507ddea5079c2429001","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/769dc8865e0dc507ddea5079c2429001"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202011191111087a393725&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202011191111087a393725&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["90009","09969"],"gpt_icon":0},{"id":"2084416290","title":"諾誠健華董事長兼CEO崔霽松博士獲評2020“年度傑出CEO”","url":"https://stock-news.laohu8.com/highlight/detail?id=2084416290","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2084416290?lang=zh_tw&edition=fundamental","pubTime":"2020-11-17 10:04","pubTimestamp":1605578640,"startTime":"0","endTime":"0","summary":"诺诚健华董事长兼CEO崔霁松博士获评2020“年度杰出CEO” 来源：美通社北京2020年11月17日 /美通社/ -- 16日晚上，中国知名的全球投资研究平台格隆汇举办的“全球投资嘉年华2020”在成都发布“2020大中华区最佳上市公司”系列榜单，凭借在企业管理和创新领域的卓越表现，诺诚健华联合创始人、董事长兼CEO崔霁松博士获得“2020年度杰出CEO”称号。崔霁松博士于2015年与世界著名结构生物学家施一公教授联合创立诺诚健华。","market":"hk","thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c"],"rights":{"source":"sina_symbol","url":"http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2020-11-17/doc-iiznctke1840324.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.extra-info, .source{#sourceStyle#;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2020-11-17/doc-iiznctke1840324.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_symbol","symbols":["90009"],"gpt_icon":0},{"id":"2084792497","title":"百濟神州、和黃醫藥、亞盛醫藥、諾誠健華等創新產品即將亮相","url":"https://stock-news.laohu8.com/highlight/detail?id=2084792497","media":"药明康德官微","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2084792497?lang=zh_tw&edition=fundamental","pubTime":"2020-11-17 07:52","pubTimestamp":1605570736,"startTime":"0","endTime":"0","summary":"百济神州、和黄医药、亚盛医药、诺诚健华等创新产品即将亮相 来源：药明康德官微第62届美国血液学会（）年会将于2020年12月5至8日举行。根据ASH年会摘要及公开资料，来自、、亚盛医药、诺诚健华、亘喜生物、等中国公司的众多创新疗法也即将在本次大会上亮相。目前，该产品已在中国提交新药上市申请，且已被纳入优先审评。本届会议上，诺诚健华将以海报的形式展示奥布替尼的多项研究数据。","market":"us","thumbnail":"https://static.tigerbbs.com/480431b5715196c0e96044cc36788e36","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/480431b5715196c0e96044cc36788e36"],"rights":{"source":"sina_symbol","url":"http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2020-11-17/doc-iiznezxs2233955.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.extra-info, .source{#sourceStyle#;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2020-11-17/doc-iiznezxs2233955.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_symbol","symbols":["BGNE","90009","159938","06160","09939"],"gpt_icon":0},{"id":"2082188015","title":"諾誠健華-B盤中異動 大幅上漲5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2082188015","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2082188015?lang=zh_tw&edition=fundamental","pubTime":"2020-11-09 13:58","pubTimestamp":1604901520,"startTime":"0","endTime":"0","summary":"2020年11月09日下午盘13时58分，诺诚健华-B股票出现异动，股价急速拉升5.11%。截至发稿，该股报11.941港元/股，成交量112.31万股，换手率0.09%，振幅4.93%。诺诚健华-B股票所在的生物技术行业中，整体涨幅为4.46%。其相关个股中，荣昌生物-B、药明巨诺-B、金斯瑞生物科技涨幅较大，振幅较大的相关个股有荣昌生物-B、金斯瑞生物科技、药明巨诺-B，振幅分别为21.31%、13.81%、13.01%。消息层面，截至13时58分，诺诚健华-B股票正面舆情新闻比例50%。","market":"hk","thumbnail":"https://static.tigerbbs.com/8593d7bafc6da002b2ab4975d4711a90","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8593d7bafc6da002b2ab4975d4711a90"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20201109135840797e15ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20201109135840797e15ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["90009","09969"],"gpt_icon":0},{"id":"2072000032","title":"諾誠健華童少靖：中國創新藥以高質量和高性價比吸引發達國家市場、並受發展中國家市場青睞是必然趨勢","url":"https://stock-news.laohu8.com/highlight/detail?id=2072000032","media":"金融界网站","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2072000032?lang=zh_tw&edition=fundamental","pubTime":"2020-09-30 11:53","pubTimestamp":1601438013,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":"https://static.tigerbbs.com/f874ded00c644297784368a7af94c8ae","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/f874ded00c644297784368a7af94c8ae"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202009301201027a222900&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202009301201027a222900&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09969","159992","90009","06978","90014"],"gpt_icon":0},{"id":"2070090418","title":"諾誠健華“泛癌種”新藥啓動臨牀試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2070090418","media":"界面","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2070090418?lang=zh_tw&edition=fundamental","pubTime":"2020-09-27 16:21","pubTimestamp":1601194860,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://static.tigerbbs.com/3c6daacf13f78492ec38a4e178ddca49","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/3c6daacf13f78492ec38a4e178ddca49"],"rights":{"source":"sina_symbol","url":"http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2020-09-27/doc-iivhuipp6780166.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.extra-info, .source{#sourceStyle#;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2020-09-27/doc-iivhuipp6780166.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_symbol","symbols":["03347","90009"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":4,"totalSize":69,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/90009\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"90009\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"90009\",market:\"HK\",delay:false,,,undefined,":{}}}